CellaVision
153.80 SEK
-1.54 %
1,478 following
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-1.54 %
-6.90 %
-7.90 %
-20.72 %
-29.29 %
-26.06 %
-28.80 %
-47.62 %
+885.90 %
CellaVision operates in the medical technology industry and focuses on the development and manufacture of systems for digital blood analysis. The company focuses on digital cell morphology and offers innovations for analyzers, instruments, reagents and software used in hematology laboratories. The company's products are aimed at healthcare institutions and laboratories worldwide. CellaVision was founded in 1994 and is headquartered in Lund, Sweden.
Read moreMarket cap
3.67B SEK
Turnover
792.53K SEK
Revenue
723.22M
EBIT %
24.57 %
P/E
26.07
Dividend yield-%
1.63 %
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
5/2
2026
Annual report '25
24/4
2026
Interim report Q1'26
28/4
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
CellaVision receives CE marking according to IVDR Class C for CellaVision® Bone Marrow Aspirate Application
CellaVision, Audiocast, Q3'25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
